{
  "id": "mhgap#screening_cues_0f1331f9",
  "content": "(RR = 1.23). Psychotherapy alone also had higher If the person does not improve with psychological\nacceptability rates compared with pharmacotherapy interventions, combined treatment can be\nalone (RR = 1.17). No significant differences considered based on individual preferences and\nwere found between combined treatment careful consideration of the balance of benefits\nand psychological interventions regarding and harms.\ntreatment acceptability.\n63\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\n3.7 Drug use disorders (DRU)\nDRU1. Are brief psychosocial interventions for people using\ncannabis or stimulants effective in reducing drug use,\ndependence and harm from drug use?\nRecommendation (update): 1.1 Adults using cannabis should be offered screening and brief intervention.\nBrief intervention should comprise at least a single session, incorporating\nindividualized feedback and advice on reducing or stopping cannabis\nconsumption, and the offer of follow-up care.\nStrength of recommendation: Strong\nCertainty of evidence: Very low\n1.2 Adults using psychostimulants should be offered screening and brief\nintervention. Brief intervention should comprise at least a single session,\nincorporating individualized feedback and advice on reducing or stopping\npsychostimulant consumption, and the offer of follow-up care.\nStrength of recommendation: Strong\nCertainty of evidence: Very low",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Screening Cues (RR = 1.23). Psychotherapy alone also had higher If the person does not improve with psychological\nacceptability rates compared with pharmacotherapy interventions, combined treatment can be\nalone (RR = 1.17). No significant differences considered based on individual preferences and\nwere found between combined treatment careful consideration of the balance of benefits\nand psychological interventions regarding and harms.\ntreatment acceptability.\n63\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\n3.7 Drug use disorders (DRU)\nDRU1. Are brief psychosocial interventions for people using\ncannabis or stimulants effective in reducing drug use,\ndependence and harm from drug use?\nRecommendation (update): 1.1 Adults using cannabis should be offered screening and brief intervention.\nBrief intervention should comprise at least a single session, incorporating\nindividualized feedback and advice on reducing or stopping cannabis\nconsumption, and the offer of follow-up care.\nStrength of recommendation: Strong\nCertainty of evidence: Very low\n1.2 Adults using psychostimulants should be offered screening and brief\nintervention. Brief intervention should comprise at least a single session,\nincorporating individualized feedback and advice on reducing or stopping\npsychostimulant consumption, and the offer of follow-up care.\nStrength of recommendation: Strong\nCertainty of evidence: Very low (rr = 1.23). psychotherapy alone also had higher if the person does not improve with psychological\nacceptability rates compared with pharmacotherapy interventions, combined treatment can be\nalone (rr = 1.17)."
}